 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cell cycle regulation
|
PDB id
|
|
|
|
1bu2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
cell cycle
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
7:245-254
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6.
|
|
U.Schulze-Gahmen,
J.U.Jung,
S.H.Kim.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Cyclin-dependent kinases (CDKs) have a central role in cell-cycle
control and are activated by complex formation with positive regulatory proteins
called cyclins and by phosphorylation. The overexpression and mutation of
cyclins and CDKs has been associated with tumorigenesis and oncogenesis. A
virus-encoded cyclin (v-cyclin) from herpesvirus saimiri has been shown to
exhibit highest sequence homology to type D cyclins and specifically activates
CDK6 of host cells to a very high degree. RESULTS: We have determined the first
X-ray structure of a v-cyclin to 3.0 A resolution. The structure of the core
domains is very similar to those of cyclin A and cyclin H from human cells. To
understand the structural basis for the v-cyclin specificity for CDK6 and the
insensitivity of the complex to inhibitors of the p21 and INK4 families, a
v-cyclin-CDK2 model was built on the basis of the known structures of human
cyclin A in complex with CDK2 and the CDK inhibitor p27(Kip1). CONCLUSIONS:
Although many critical interactions between cyclin A and CDK2 would be conserved
in a v-cyclin-CDK2 complex, some appear sterically or electrostatically
unfavorable due to shifts in the backbone conformation or sidechain differences
and may contribute to v-cyclin selectivity for CDK6. The insensitivity of
v-cyclin-CDK6 complexes to inhibitors of the p21 family is probably due to
structural changes in v-cyclin that lead to a flatter surface area offering
fewer potential contacts with the protein inhibitor. In addition, sequence
changes in v-cyclin eliminate hydrogen-bonding partners for atoms of the
p27(Kip1) inhibitor. This structure provides the first model for interactions
between v-cyclins and host cell-cycle proteins; these interactions may be
important for virus survival as well as oncogenic transformation of host cells.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 5.
Figure 5. Schematic drawing of the molecular contacts between
v-cyclin and CDK2 in a model complex based on the
cyclin-A–CDK2 complex. v-Cyclin is shown in blue, CDK2 in
orange and cyclin A in green. (a) The conserved hydrogen bonds
between Glu136 and Lys107 in v-cyclin and the backbone atoms of
residues 42–44 in CDK2. The sidechains of residues 42–44 are
omitted for clarity. Conserved hydrogen bonds are indicated as
broken lines. The dotted line indicates a contact that is too
long for a hydrogen bond in the v-cyclin–CDK2 complex, but
could probably be formed after minor structural changes in
either molecule. (b) Schematic drawing of the close interactions
between residues 111–113 in v-cyclin and residues 46–50 in
the PSTAIRE helix of CDK2, the T loop residues 159–162 and
Arg150. The backbone structure of cyclin A is shown for
comparison. (c) Potential contact residues for the v-cyclin
residue Trp145. Too close contacts with His71 in CDK2 are
probably caused by a shift in the Trp145 position due to crystal
contacts. If Trp145 is overlapped onto the equivalent Phe304 in
cyclin A, more favorable interactions with Ile52 and Val69 in
CDK2 can be formed. (d) A patch of closely positioned charged
residues in a modeled v-cyclin–CDK2 complex. In particular,
residues Arg30 in v-cyclin and Arg122 in CDK2 are in too close
contact. (The figures were made using the program MOLSCRIPT
[50].)
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1999,
7,
245-254)
copyright 1999.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Baek,
R.S.Brown,
G.Birrane,
and
J.A.Ladias
(2007).
Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9.
|
| |
J Mol Biol, 366,
563-573.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Sridhar,
N.Akula,
and
N.Pattabiraman
(2006).
Selectivity and potency of cyclin-dependent kinase inhibitors.
|
| |
AAPS J, 8,
E204-E221.
|
 |
|
|
|
|
 |
D.Das,
N.Oganesyan,
H.Yokota,
R.Pufan,
R.Kim,
and
S.H.Kim
(2005).
Crystal structure of the conserved hypothetical protein MPN330 (GI: 1674200) from Mycoplasma pneumoniae.
|
| |
Proteins, 58,
504-508.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.S.Moore,
and
Y.Chang
(2003).
Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?
|
| |
Annu Rev Microbiol, 57,
609-639.
|
 |
|
|
|
|
 |
U.Schulze-Gahmen,
and
S.H.Kim
(2002).
Structural basis for CDK6 activation by a virus-encoded cyclin.
|
| |
Nat Struct Biol, 9,
177-181.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Swanton,
and
N.Jones
(2001).
Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.
|
| |
Int J Exp Pathol, 82,
3.
|
 |
|
|
|
|
 |
H.Laman,
D.Coverley,
T.Krude,
R.Laskey,
and
N.Jones
(2001).
Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication.
|
| |
Mol Cell Biol, 21,
624-635.
|
 |
|
|
|
|
 |
P.Kaldis,
P.M.Ojala,
L.Tong,
T.P.Mäkelä,
and
M.J.Solomon
(2001).
CAK-independent activation of CDK6 by a viral cyclin.
|
| |
Mol Biol Cell, 12,
3987-3999.
|
 |
|
|
|
|
 |
U.Schulze-Gahmen,
and
S.H.Kim
(2001).
Crystallization of a complex between human CDK6 and a virus-encoded cyclin is critically dependent on the addition of small charged organic molecules.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
1287-1289.
|
 |
|
|
|
|
 |
G.L.Card,
P.Knowles,
H.Laman,
N.Jones,
and
N.Q.McDonald
(2000).
Crystal structure of a gamma-herpesvirus cyclin-cdk complex.
|
| |
EMBO J, 19,
2877-2888.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Laman,
D.J.Mann,
and
N.C.Jones
(2000).
Viral-encoded cyclins.
|
| |
Curr Opin Genet Dev, 10,
70-74.
|
 |
|
|
|
|
 |
L.F.van Dyk,
H.W.Virgin,
and
S.H.Speck
(2000).
The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.
|
| |
J Virol, 74,
7451-7461.
|
 |
|
|
|
|
 |
J.A.Endicott,
M.E.Noble,
and
J.A.Tucker
(1999).
Cyclin-dependent kinases: inhibition and substrate recognition.
|
| |
Curr Opin Struct Biol, 9,
738-744.
|
 |
|
|
|
|
 |
J.C.Beauchamp,
and
N.W.Isaacs
(1999).
Methods for X-ray diffraction analysis of macromolecular structures.
|
| |
Curr Opin Chem Biol, 3,
525-529.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|